Annual SG&A
$22.32 M
-$691.30 K-3.00%
31 December 2023
Summary:
MoonLake Immunotherapeutics annual selling, general & administrative expenses is currently $22.32 million, with the most recent change of -$691.30 thousand (-3.00%) on 31 December 2023. MLTX annual SG&A is now -3.00% below its all-time high of $23.01 million, reached on 31 December 2022.MLTX Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$7.38 M
+$460.40 K+6.66%
30 September 2024
Summary:
MoonLake Immunotherapeutics quarterly selling, general & administrative expenses is currently $7.38 million, with the most recent change of +$460.40 thousand (+6.66%) on 30 September 2024. Over the past year, it has increased by +$1.98 million (+36.81%). MLTX quarterly SG&A is now at all-time high.MLTX Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$591.58 M
-$80.77 M-15.81%
30 September 2024
Summary:
MoonLake Immunotherapeutics TTM selling, general & administrative expenses is currently -$591.58 million, with the most recent change of -$80.77 million (-15.81%) on 30 September 2024. Over the past year, it has dropped by -$612.29 million (-2955.45%). MLTX TTM SG&A is now -1002.79% below its all-time high of $28.03 million, reached on 30 September 2024.MLTX TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MLTX Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -3.0% | +36.8% | -2955.4% |
| 3 y3 years | - | +31.8% | -7132.1% |
| 5 y5 years | - | - | - |
MLTX Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -3.0% | at low | at high | +64.6% | -1002.8% | at low |
| 5 y | 5 years | -3.0% | at low | at high | +162.1% | -1002.8% | at low |
| alltime | all time | -3.0% | at low | at high | +162.1% | -1002.8% | at low |
MoonLake Immunotherapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $7.38 M(+6.7%) | $28.03 M(+7.6%) |
| June 2024 | - | $6.92 M(+1.6%) | $26.05 M(+10.3%) |
| Mar 2024 | - | $6.81 M(-1.8%) | $23.61 M(+5.8%) |
| Dec 2023 | $22.32 M | $6.93 M(+28.6%) | $22.32 M(+7.7%) |
| Sept 2023 | - | $5.39 M(+20.3%) | $20.72 M(-1.7%) |
| June 2023 | - | $4.48 M(-18.8%) | $21.07 M(-7.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | $5.52 M(+3.6%) | $22.84 M(+0.1%) |
| Dec 2022 | $23.01 M | $5.33 M(-7.3%) | $22.81 M(+30.5%) |
| Sept 2022 | - | $5.75 M(-8.1%) | $17.49 M(+0.9%) |
| June 2022 | - | $6.25 M(+13.9%) | $17.34 M(+24.7%) |
| Mar 2022 | - | $5.49 M(-2.0%) | $13.90 M(+65.2%) |
| Sept 2021 | - | $5.60 M(+98.9%) | $8.41 M(+198.9%) |
| June 2021 | - | $2.81 M | $2.81 M |
FAQ
- What is MoonLake Immunotherapeutics annual selling, general & administrative expenses?
- What is the all time high annual SG&A for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics annual SG&A year-on-year change?
- What is MoonLake Immunotherapeutics quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics quarterly SG&A year-on-year change?
- What is MoonLake Immunotherapeutics TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics TTM SG&A year-on-year change?
What is MoonLake Immunotherapeutics annual selling, general & administrative expenses?
The current annual SG&A of MLTX is $22.32 M
What is the all time high annual SG&A for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high annual selling, general & administrative expenses is $23.01 M
What is MoonLake Immunotherapeutics annual SG&A year-on-year change?
Over the past year, MLTX annual selling, general & administrative expenses has changed by -$691.30 K (-3.00%)
What is MoonLake Immunotherapeutics quarterly selling, general & administrative expenses?
The current quarterly SG&A of MLTX is $7.38 M
What is the all time high quarterly SG&A for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high quarterly selling, general & administrative expenses is $7.38 M
What is MoonLake Immunotherapeutics quarterly SG&A year-on-year change?
Over the past year, MLTX quarterly selling, general & administrative expenses has changed by +$1.98 M (+36.81%)
What is MoonLake Immunotherapeutics TTM selling, general & administrative expenses?
The current TTM SG&A of MLTX is -$591.58 M
What is the all time high TTM SG&A for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high TTM selling, general & administrative expenses is $28.03 M
What is MoonLake Immunotherapeutics TTM SG&A year-on-year change?
Over the past year, MLTX TTM selling, general & administrative expenses has changed by -$612.29 M (-2955.45%)